| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 47.224 | 48.186 | 46.355 | 56.839 | 60.317 | 28.105 | 77.575 | 8.016 | 1.919 | 31.029 |
| Total Income - EUR | 47.224 | 49.392 | 46.355 | 56.839 | 60.317 | 28.105 | 77.575 | 8.016 | 1.919 | 31.029 |
| Total Expenses - EUR | 43.233 | 44.997 | 47.914 | 52.964 | 60.168 | 23.757 | 58.908 | 6.418 | 1.842 | 25.088 |
| Gross Profit/Loss - EUR | 3.991 | 4.395 | -1.560 | 3.875 | 149 | 4.348 | 18.667 | 1.598 | 77 | 5.941 |
| Net Profit/Loss - EUR | 2.584 | 3.424 | -2.023 | 3.106 | -256 | 3.715 | 17.289 | 1.380 | 65 | 4.684 |
| Employees | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
Check the financial reports for the company - Novaterm Plus Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 83 | 19 | 0 | 0 | 217 | 125 | 16 | 0 | 0 | 0 |
| Current Assets | 11.333 | 5.636 | 4.178 | 11.356 | 5.507 | 8.662 | 20.764 | 4.643 | 2.588 | 16.503 |
| Inventories | 2.822 | 3.185 | 3.175 | 7.638 | 1.073 | 1.391 | 143 | 470 | 6 | 355 |
| Receivables | 576 | 0 | 0 | 2.135 | 1.988 | 2.410 | 5.822 | 3.074 | 2.517 | 12.488 |
| Cash | 7.935 | 2.451 | 1.003 | 1.583 | 2.446 | 4.862 | 14.799 | 1.099 | 65 | 3.661 |
| Shareholders Funds | 10.721 | 3.793 | 1.705 | 4.780 | 4.431 | 8.062 | 19.714 | 4.121 | 2.354 | 7.025 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 695 | 1.862 | 2.473 | 6.576 | 1.293 | 724 | 1.067 | 521 | 234 | 9.478 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4752 - 4752" | |||||||||
| CAEN Financial Year |
4752
|
|||||||||
Comments - Novaterm Plus Srl